Condition : Acromegaly Interventions : Drug: Pasireotide (SOM230); Drug: octreotide LAR 30mg or lanreotide ATG 120mg Sponsor : Novartis Pharmaceuticals Recruiting - verified July 2011

Conditions : Neuropathic Pain; Spinal Stenosis Intervention : Drug: transdermal fentanyl matrix, gabapentin Sponsors

Condition : Spinal Diseases Intervention : Device: DensiProbe Spine Sponsors : AO Clinical Investigation and Documentation; University Hospital Inselspital, Berne Recruiting - verified July 2011

Conditions : Osteoporosis; Fracture; Aging Intervention : Sponsors : Artann Laboratories; National Institutes of Health (NIH); National Institute on Aging (NIA); Mayo Clinic Active, not recruiting - v...

Condition : Degenerative Disc Disease Interventions : Drug: Intradiscal rhGDF-5; Other: Water for injection Sponsors : Advanced Technologies and Regenerative Medicine, LLC (ATRM); DePuy Spine Recruiti...

Condition : Osteoporosis Interventions : Drug: Odanacatib; Drug: Placebo for Odanacatib Sponsor : Merck Active, not recruiting - verified July 2011

Condition : Ankylosing Spondylitis Intervention : Drug: SAR153191 (REGN 88) Sponsors : Sanofi-Aventis; Regeneron Pharmaceuticals Active, not recruiting - verified March 2011

Condition : Ankylosing Spondylitis Intervention : Drug: SAR153191 (REGN 88) Sponsors : Sanofi-Aventis; Regeneron Pharmaceuticals Active, not recruiting - verified March 2011

Condition : Post-Menopausal Osteoporosis Interventions : Drug: ibandronate [Bonviva/Boniva]; Drug: alendronate Sponsor : Hoffmann-La Roche Recruiting - verified July 2011

Condition : Growth Hormone Deficiency Interventions : Device: Genotropin Pen; Device: MARK VII pen; Device: Genotropin Pen; Device: MARK VII pen Sponsor : Pfizer Recruiting - verified August 2011